Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

External Oblique Intercostal Block With or Without Lidocaine for Pain After Gastric Bypass

Official title: External Oblique Intercostal Block With or Without Intravenous Lidocaine Infusion for Analgesia in Patients Undergoing Gastric Bypass Surgery: a Randomized Controlled Trial

Run by Menoufia University · NCT07809425 · Data updated 2026-11-12

This study tests whether adding a lidocaine IV infusion to a bilateral EOIB with low-dose fentanyl helps manage pain during gastric bypass in obese adults.

More Obese Patients trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment100 (estimated)
SponsorMenoufia University
Academic / other
Locations1 site (Alexandria)
StatusRecruiting
StartedSeptember 15, 2026
Main results expectedJanuary 15, 2027
Study endsFebruary 1, 2027
Registry record updatedSeptember 11, 2026
Trial IDNCT07809425 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–60 with BMI ≥35 undergoing elective laparoscopic Roux-en-Y gastric bypass, ASA II–III, able to consent.

Probably not a fit

Patients with lidocaine intolerance, hepatic or renal impairment, severe allergies, or where EOIB fails to provide sensory loss may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial examines if a perioperative lidocaine infusion (loading dose 1.5 mg/kg followed by 1.5 mg/kg/h) added to bilateral external oblique intercostal blocks and a low-dose fentanyl loading reduces intraoperative fentanyl needs compared with placebo, without increasing adverse events. Participants are adults aged 18–60 with BMI ≥35 kg/m² and undergoing elective laparoscopic Roux-en-Y gastric bypass. The intervention group receives lidocaine infusion and EOIB with fentanyl loading, while the control receives normal saline in place of lidocaine and similar regional anesthesia. Outcomes focus on intraoperative fentanyl consumption and safety signals, with ANI-guided rescue allowed as per protocol. Exclusion criteria include lidocaine allergy, chronic opioid use, hepatic or renal impairment, certain cardiac conditions, pregnancy, coagulopathy, infection at block site, and failed EOIB. Lead sponsor is Menoufia University, with a single site in Alexandria, Egypt.

Why it matters

Potential benefit: If successful, the approach could reduce intraoperative opioid needs and potentially improve pain control after gastric bypass without adding risks.

How similar studies have gone: Prior work in regional anesthesia and perioperative lidocaine has shown analgesic benefits in similar settings, but this exact combination is recent and somewhat novel for this procedure.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-60 years.
* BMI ≥ 35 kg/m².
* ASA physical status II or III.
* Scheduled for elective laparoscopic Roux en Y gastric bypass.
* Ability to provide written informed consent.

Exclusion Criteria:

* Refusal.
* Allergy or contraindication to lidocaine, fentanyl, ropivacaine, or any study medication.
* Chronic opioid use or dependence.
* Significant hepatic (AST/ALT\> 3× normal, cirrhosis) or renal impairment (CrCl\< 30 mL/min).
* Second or third degree AV block or significant bradyarrhythmia without pacemaker.
* Coagulopathy, anticoagulation incompatible with regional anesthesia, or infection at block site.
* Pregnancy or lactation.
* Severe psychiatric or cognitive disorder.
* Failed bilateral EOIB (absence of sensory loss in T6-T10 after 30 min) - excluded from analysis.

Where it's running

  • Faculty of Medicine
    Alexandria, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.